Skip to primary navigation
Skip to main content
Skip to primary sidebar
Skip to footer
BerGenBio
Selective AXL inhibitors
About BerGenBio
About BerGenBio
Management Team
Board of Directors
Partners
Pipeline
Pipeline overview
bemcentinib | NSCLC
bemcentinib | COVID-19
bemcentinib | Melanoma
bemcentinib | AML
BGB149
BGB601
Discovery
Publications
Expanded access policy
Media Centre
News
Events
COVID-19 Media Pack
Media Contacts
Investors
Share Information
Largest Shareholders
Stock Exchange Notices
Presentations
Financial Reports
Financial Calendar
Analysts
General Meetings
Corporate Governance
IR Contacts
Careers
Contact
Home
/
Investors
/
Stock Exchange Notices
Stock Exchange Notices